|
SCAND1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.92111999999245E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.020170E-03 |
| Normal-vs-Stage2 |
2.937900E-02 |
| Normal-vs-Stage3 |
1.323580E-03 |
| Normal-vs-Stage4 |
7.008200E-04 |
| Stage1-vs-Stage2 |
9.556800E-01 |
| Stage1-vs-Stage3 |
5.592600E-01 |
| Stage1-vs-Stage4 |
4.176800E-01 |
| Stage2-vs-Stage3 |
7.147800E-01 |
| Stage2-vs-Stage4 |
5.800800E-01 |
| Stage3-vs-Stage4 |
8.506400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.395100E-03 |
| Normal-vs-AfricanAmerican |
1.21909999872827E-08 |
| Normal-vs-Asian |
5.147800E-01 |
| Caucasian-vs-AfricanAmerican |
8.63469999945465E-07 |
| Caucasian-vs-Asian |
7.132800E-01 |
| AfricanAmerican-vs-Asian |
2.042400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.626500E-04 |
| Normal-vs-Female |
4.29809999999975E-05 |
| Male-vs-Female |
1.766560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.158000E-02 |
| Normal-vs-Age(41-60Yrs) |
6.394500E-04 |
| Normal-vs-Age(61-80Yrs) |
4.166700E-04 |
| Normal-vs-Age(81-100Yrs) |
2.276500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.134600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.992800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.723000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.842800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.237400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.807600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.281800E-02 |
| Normal-vs-Grade 2 |
4.025000E-03 |
| Normal-vs-Grade 3 |
5.65879999999686E-05 |
| Normal-vs-Grade 4 |
9.424000E-03 |
| Grade 1-vs-Grade 2 |
1.680600E-01 |
| Grade 1-vs-Grade 3 |
3.578600E-01 |
| Grade 1-vs-Grade 4 |
2.917400E-01 |
| Grade 2-vs-Grade 3 |
2.059800E-01 |
| Grade 2-vs-Grade 4 |
5.667800E-01 |
| Grade 3-vs-Grade 4 |
7.261800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.702600E-01 |
| Normal-vs-ccB subtype |
1.056380E-01 |
| ccA subtype-vs-ccB subtype |
3.323400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.402800E-03 |
| Normal-vs-N1 |
3.588400E-01 |
| N0-vs-N1 |
8.616400E-01 |
|
|
